Topline results from Phase 3 EPCORE DLBCL-4 trial evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-fr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results